S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

RLMD Relmada Therapeutics Inc

3.0099

-0.0001 (0.00%)

Last Updated: 10:15:45

Delayed by 15 minutes

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Relmada Therapeutics (NASDAQ:RLMD)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Relmada Therapeutics Charts.

Relmada Therapeutics (NASDAQ:RLMD)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Relmada Therapeutics Charts.

Relmada Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 8 May 2024 (1 month ago) • Edgar (US Regulatory)

US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat
Tuesday 19 March 2024 (3 months ago) • IH Market News

Form 144 - Report of proposed sale of securities
Tuesday 20 February 2024 (4 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 31 January 2024 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 31 January 2024 (5 months ago) • Edgar (US Regulatory)

More Relmada Therapeutics Inc News Articles

Virexit Technologies (PK)

Cann American (CE)

RespireRx Pharmaceuticals (PK)

Hannover House (PK)

Golden Triangle Ventures (PK)

SMC Entertainment (PK)

Rennova Health (PK)

Kraig Biocraft Laborator... (QB)

International Star (PK)

ERHC Energy (CE)

CTR Investments and Cons... (PK)

Ronn Motor (PK)

Anavex Life Sciences

Digital Brand Media and ... (PK)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions